fbpx

FYidoctors Adds First Clinic in Fort McMurray

FYidoctors announces the addition of Fort McMurray’s premiere medical aesthetics clinic, YMM Cosmetic and Laser Clinic (YMM) to its expanding aesthetic medicine business unit. Experiencing record growth in 2021, the addition marks FYidoctors’ ninth clinic in Alberta, with continued plans for expansion across Canada in the coming months.

“We’re thrilled to welcome YMM Cosmetic and Laser Clinic to FYidoctors’ aesthetic medical business unit, and to continue reaching new patients in Western Canada,” said Dr. Alan Ulsifer, CEO and Chairman of FYidoctors. “As the leading clinic in the region, we couldn’t be more excited to build on the clinic’s outstanding reputation and to start working with Dr. Hibbitts and her team of highly skilled professionals.”

Founded in 2015 by husband-and-wife duo Dr. Erin Hibbitts and business manager, Patrick Hibbitts, the team brings to the practice a blend of business expertise, clinical experience, and best-in-class training in aesthetic medicine to its patients.

“We saw an incredible opportunity for growth in partnering with FYidoctors, and how this could improve not only our medical practice but the products, technology and services available to our patients in Fort McMurray,” said Dr. Erin Hibbitts. 

Click HERE for the full press release.

Other related articles

Essilor and Luxottica launch EssilorLuxottica 360™, the Companies’ First Joint Commercial Program in Canada

Essilor and Luxottica, divisions of EssilorLuxottica Canada, bring to the Canadian market EssilorLuxottica 360, a new joint program that will drive growth for independent eye care professionals. This program comes at a time when independent ECPs can use the support of their industry partners. EssilorLuxottica 360 is designed to help ECPs increase their traffic, visibility, and capture rate, as well as provide added support to provide an enhanced patient experience and help improve practice profitability.

ECPs working to build back their business post-Covid will have the full power of Essilor and Luxottica behind them. Because patient traffic is the lifeblood of every practice, EssilorLuxottica 360 is designed to help drive patients to your practice and increase visibility driven by advertising and digital marketing tools.

With the ECPs’ virtual and social footprint growing in importance, EssilorLuxottica 360 will give members access to EssilorLuxottica’s digital tools such as the Smart Shopper, which enhances the shopping experience, creates an endless aisle of products and styles to showcase and offers virtual try-on tools. Members will also have access to product customization tools for Ray-Ban® and Oakley® as well as Luxottica’s digital screens. EssilorLuxottica has also invested in tools to help ECPs manage and amplify their own social media channels with branded content to drive consumers to their practice with Promoboxx™ and Essilor® Experts.

Members will also have access to EssilorLuxottica’s brand-new learning platform Leonardo™ that provides an innovative learning experience and brings a new perspective with best-in-class learning content taught by experts in the field.

EssilorLuxottica 360 will be available to Essilor® Experts that wish to strengthen their practice through a strong portfolio of Luxottica brands and Essilor advanced lens technology. Members of EssilorLuxottica 360 will have access to special commercial terms on their Luxottica Frame purchases and a flexible Incentive Jumpstart benefit that lets you explore new brands for your practice.

“Building on the positive results of our Essilor® Experts program for our independent partners, we are pleased to offer them even more benefits and ways to grow through EssilorLuxottica 360,” said Christophe Perreault, President of Essilor Canada. “This new program is an opportunity to strengthen our partnership with doctors and independent opticians across the country by providing them with a range of innovative tools to always better meet their customers’ expectations, at the best commercial conditions.”

“When it comes to eyewear, consumer trends and digitalization have accelerated in recent months. Consumers look for recognized brands,” said Ludovic Ladreyt, Senior Vice President of Optical Sales, Luxottica Wholesale North America. “EssilorLuxottica 360 is built to help independent eyecare professionals face these changes giving them a range of digital tools and special commercial terms on their Luxottica Frame purchases that let them explore new brands for their practice.”

Click HERE for the full press release.

Aequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology Expertise

Aequus Pharmaceuticals (Aequus) a speciality pharmaceutical company, announces that Dr. Robert K. Koenekoop MD, MSc, PhD, FRCS(C), FARVO has joined as a medical and clinical consultant to Aequus on inherited retinal diseases, and specifically to support Aequus’ collaboration with reVision Therapeutics for the product REV-0100, a potential therapy for Stargardt disease.

Dr. Koenekoop is a Pediatric Ophthalmologist and Director of Pediatric Ophthalmology and Molecular Biology of Blindness at the Montreal Children’s Hospital (MCH). He also holds positions as Professor of Paediatric Surgery, Human Genetics and Adult Ophthalmology at McGill University and Director of the Laboratory for Retinal Genetics and Therapeutics, and Chief of Paediatric Ophthalmology at MCH Glen site.

Dr. Koenekoop brings over 25 years of national and international basic and clinical research expertise in ophthalmology, in both children and adults. With Dr. Koenekoop’s expert background and medical practice in Canada for inherited retinal diseases, his valuable insights will help the REV-0100 programme move forward.

“Stargardt macular dystrophy and all the other inherited retinal degenerations were deemed untreatable by the discoverers of these diseases and many generations of clinical teachers and researchers in this field,” said Dr. Koenekoop. “It is very exciting after all these years of seeing patients’ vision decline, that now for the first time we are seeing stabilization and even improvements in vision with some of the experimental agents.”

REV-0100 is a potential therapy for patients with Stargardt disease that is designed to bind and clear a toxic lipid called lipofuscin. Accumulation of lipofuscin in Stargardt disease leads to cell death and retinal degeneration. REV-0100 has the potential to reduce lipofuscin levels in the retina.

Click HERE for the full press release.

Earlier in August, Aequus announced a collaboration with reVision Therapeutics- See full press release HERE.

WCO Launches Myopia Management Online Resource

World Council of Optometry and CooperVision logos

The World Council of Optometry (WCO) and CooperVision have jointly developed an easy-to-use online resource that provides multilingual assets and approaches that will enable eye care professionals to apply a standard of care to manage the condition. The resource site is live and can be found HERE.

“This online resource provides eye care practitioners from anywhere in the world access to the information they need to implement a standard of care to treat or manage a patient’s myopia progression,” said Paul Folkesson, president, World Council of Optometry. “Thanks to the support of CooperVision, information regarding the treatment of myopia is more accessible than ever before. This is just the start as we work to provide more materials and educational programming through this collaborative partnership.”

The myopia online resource was developed to serve as a valuable point to provide information that has not been easily accessible and provide a forum to encourage the exchange of knowledge and experiences within the global optometric community. The site is organized around the three main pillars of the evidence-based standard of care unanimously adopted by the WCO Board of Directors—mitigation, measurement and management. Each pillar provides a listing of papers and studies that have been distilled into one-page “Myopia Moments” that are available in Arabic, Chinese, English, French, Russian and Spanish. Visitors to the site can download a Myopia Moment—giving them evidence-based guidance about providing care to a patient—or they can learn more by accessing the many papers and studies that have been aggregated from independent third-party sources.

Click HERE for the full press release.

Safilo and Chiara Ferragni Sign New Licensing Agreement for Eyewear Collection

Safilo and Chiara Ferragni, entrepreneur and global fashion icon, announce their new multi-year global licensing agreement for the design, manufacture and distribution of the first Chiara Ferragni branded eyewear collection.

The full eyewear range – both optical and sun – will be unveiled for the SS22 season, hitting the market in January 2022.

We are excited to welcome to our portfolio one of the most famous and powerful digital entrepreneurs in the world,” declared Angelo Trocchia, CEO of Safilo Group. “Together, we want to create a new leading and digitally boosted fashion eyewear brand that directly speaks to new generations, working in synergy with the extraordinary power of Chiara’s global fan base to further strengthen the presence of Safilo in the digital universe.”

Safilo represents not only excellence in eyewear but also, similarly to my brand, a great example of Italian spirit with a global reach,” stated Chiara Ferragni, CEO and Creative Director of Chiara Ferragni brand. “They strongly believed in my brand and in developing this new category.

Over the past months, Safilo has been accelerating on its digital transformation projects, working to be at the forefront of seizing the opportunities of the digital business and making significant progress in terms of product offer, service level, customer engagement and digital connection. The new agreement with Chiara Ferragni, marking her namesake brand’s entry into eyewear licensing, goes in this same direction of digital transformation and active engagement strategy, addressing new generations through new languages and channels to reflect what is happening in the marketplace.

Click HERE for the full press release.

Other related articles

Featured Posts

Canadian Association of Optometrists logo

Don’t Let “The Blur” Stand in the Way of Children’s Learning

CAO launches a national awareness campaign highlighting the importance of regular eye exams for children and the rising prevalence of early onset myopia.

Learn More
Pediatric eye care practice growth

Children: The Hidden Treasure of Practice Building

Discover how prioritizing pediatric eye care drives generational practice growth and builds lasting patient loyalty. Expert practice-building insights by Dr. Diana M. Monea.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Dr. Brianna Rhue joins Eye on the Industry for a lively discussion about AI, practice technology, patient experience, leadership and the business of optometry.

Read more
Oakley 2026_Football_JJ_Sig_Series_Highland_JustinJefferson_2483_2834

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

Oakley and Justin Jefferson introduce a new Signature Series featuring elevated materials, bold styling and performance driven eyewear.

Read more
BostonSight logo

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

BostonSight and LVPEI launch a clinical study to evaluate how PROSE treatment and scleral lenses may affect mental health outcomes.

Read more
Canadian Association of Optometrists logo

Don’t Let “The Blur” Stand in the Way of Children’s Learning

CAO launches a national awareness campaign highlighting the importance of regular eye exams for children and the rising prevalence of early onset myopia.

Learn More
Pediatric eye care practice growth

Children: The Hidden Treasure of Practice Building

Discover how prioritizing pediatric eye care drives generational practice growth and builds lasting patient loyalty. Expert practice-building insights by Dr. Diana M. Monea.

Read More
Eye On the Industry podcast EOTI

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Dr. Brianna Rhue joins Eye on the Industry for a lively discussion about AI, practice technology, patient experience, leadership and the business of optometry.

Read More
Oakley 2026_Football_JJ_Sig_Series_Highland_JustinJefferson_2483_2834

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

Oakley and Justin Jefferson introduce a new Signature Series featuring elevated materials, bold styling and performance driven eyewear.

Read More
BostonSight logo

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

BostonSight and LVPEI launch a clinical study to evaluate how PROSE treatment and scleral lenses may affect mental health outcomes.

Read More
Canadian Association of Optometrists logo

Don’t Let “The Blur” Stand in the Way of Children’s Learning

CAO launches a national awareness campaign highlighting the importance of regular eye exams for children and the rising prevalence of early onset myopia.

Learn More
Pediatric eye care practice growth

Children: The Hidden Treasure of Practice Building

Discover how prioritizing pediatric eye care drives generational practice growth and builds lasting patient loyalty. Expert practice-building insights by Dr. Diana M. Monea.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Dr. Brianna Rhue joins Eye on the Industry for a lively discussion about AI, practice technology, patient experience, leadership and the business of optometry.

Read more
Oakley 2026_Football_JJ_Sig_Series_Highland_JustinJefferson_2483_2834

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

Oakley and Justin Jefferson introduce a new Signature Series featuring elevated materials, bold styling and performance driven eyewear.

Read more
BostonSight logo

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

BostonSight and LVPEI launch a clinical study to evaluate how PROSE treatment and scleral lenses may affect mental health outcomes.

Read more
Canadian Association of Optometrists logo

Don’t Let “The Blur” Stand in the Way of Children’s Learning

CAO launches a national awareness campaign highlighting the importance of regular eye exams for children and the rising prevalence of early onset myopia.

Learn More
Pediatric eye care practice growth

Children: The Hidden Treasure of Practice Building

Discover how prioritizing pediatric eye care drives generational practice growth and builds lasting patient loyalty. Expert practice-building insights by Dr. Diana M. Monea.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Episode 13: Dr. Brianna Rhue on AI, Innovation and Thinking Like an Owner

Dr. Brianna Rhue joins Eye on the Industry for a lively discussion about AI, practice technology, patient experience, leadership and the business of optometry.

Read more
Oakley 2026_Football_JJ_Sig_Series_Highland_JustinJefferson_2483_2834

Oakley and Justin Jefferson Add a New Chapter to the Signature Series

Oakley and Justin Jefferson introduce a new Signature Series featuring elevated materials, bold styling and performance driven eyewear.

Read more
BostonSight logo

BostonSight and LV Prasad Eye Institute Announce Study on the Effect of PROSE and Scleral Lenses on Mental Health

BostonSight and LVPEI launch a clinical study to evaluate how PROSE treatment and scleral lenses may affect mental health outcomes.

Read more